- 2001. Housekeeping Gene
- [Genes that are expressed at a fairly consistent level throughout the cell cycle and from tissue to tissue. Usually involved in routine cellular metabolism. Often used for comparison when studying expression of other genes of interest. ( NCI )] (UMLS (NCI) C1334046) =Gene or Genome
| - 2051. HS
- [the hour of sleep ( HL7V3.0 )] (UMLS (HL7) C1611093) =Temporal Concept ;
=TimingEvent;
|
- 2002. housing
- [living facilities for humans. ( CSP )] (UMLS (CSP) C0020056) =Manufactured Object ;
=social environment;
| - 2052. hSARA
- [Encoded by MADHIP Gene, ubiquitous cytoplasmic SARA contains a FYVE domain zinc finger, seen in signaling molecules and required for SARA localization but not SMAD interaction. Able to bind PI-3 phosphate, SARA recruits SMAD2/3 to TGFBR. The SMAD binding domain (SBD) of SARA interacts with the SMAD2/3 MH2 domain; the C-terminal domain interacts with TGFBR. SMAD2/SMAD3 phosphorylation induces SARA dissociation, SMAD2/SMAD4 formation, and SMAD nuclear translocation. Alternate isoforms represent full-length (1425-aa, 156-kD) or truncated protein (1210-aa and 762-aa). Disruption of MADHIP appears to be involved in Alzheimer's disease. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0761585) MAD (Mothers Against Decapentaplegic, Drosophila) Homolog Interacting Protein, Receptor Activation Anchor;
MADH-Interacting Protein;
MADHIP;
Mothers Against Decapentaplegic Homolog Interacting Protein;
Novel Serine Protease;
NSP;
Receptor Activation Anchor Protein;
SARA Protein;
SMAD Anchor for Receptor Activation =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 2003. Housing, household, and economic circumstances
- [ ] (UMLS (ICD9CM) C0260791) =Finding
| - 2053. HSCR1
- [Human Oncogene RET is a mutated variant of RET Gene, which encodes Tyrosine-Protein Kinase Receptor RET, a type I membrane protein receptor for Glial Cell Line-Derived Neurotrophic Factor with an extracellular cadherin-like domain and important in neural crest development. Some oncogenic RET point mutations cause constitutive kinase activation. PTC1 oncogene involves fusion of RET kinase to the H4 dimerization leucine zipper. In PTC6, RET is fused to the N-terminal part of Transcriptional Intermediary Factor-1-alpha. In PTC7, RET is fused to a C-terminal part of TIF1-gamma. Oncogenic RET mutations are associated with Hirschsprung's disease, Multiple Endocrine Neoplasia, pheochromocytoma, hyperparathyroidism and medullary thyroid cancer. Oncogene RET disrupts normal cell function. ( NCI )] (UMLS (NCI) C0813143) MEN2A;
MEN2B;
MTC1;
Oncogene RET;
PTC Oncogene;
RET;
=Gene or Genome |
- 2004. HOUSING/ECONO CIRCUM NEC
- [ ] (UMLS (ICD9CM) C0260798) =Finding
| - 2054. HSD17B2
- [This gene plays a role in hormonal signaling. ( NCI )] (UMLS (NCI) C1333926) HSD17B2 Gene;
Hydroxysteroid (17-beta) Dehydrogenase 2 Gene =Gene or Genome ;
|
- 2005. HOUSING/ECONO CIRCUM NOS
- [ ] (UMLS (ICD9CM) C0260799) =Finding
| - 2055. HSD17B7
- [This gene is involved in regulation of the biological potency of certain steroids. ( NCI )] (UMLS (NCI) C1333927) HSD17B7 Gene;
Hydroxysteroid (17-beta) Dehydrogenase 7 Gene =Gene or Genome ;
|
- 2006. how applies
- [Description of how set or code applies ( HL7V3.0 )] (UMLS (HL7) C1553880) =Idea or Concept =HL7 Value Set and Coded Concept Property Codes;
| - 2056. HsEg5 Protein
- (UMLS (NCI) C1173400) Human Eg5 Protein;
Human Kinesin Spindle Protein;
Kinesin Family Member 11;
Kinesin Heavy Chain;
Kinesin-Like 1 Protein;
KNSL1 Protein;
Thyroid Receptor Interacting Protein 5;
Xenopus Homolog of Eg5 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 2007. HOX protein
- [ ] (UMLS (CSP) C0599737) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 2057. HSG (hysterosalpingogram)
- [Radiography of the uterus and fallopian tubes after the injection of a contrast medium. ( MSH )] (UMLS (CSP) C0020709) =Diagnostic Procedure
|
- 2008. HPA
- [interaction and feedback in stimulation or suppression of hormones produced in the hypothalamus, pituitary, and adrenal glands. ( CSP )] (UMLS (CSP) C0597719) =Body System ;
=neuroendocrine;
=pituitary adrenal axis;
hypothalamic pituitary axis;
| - 2058. hsides
- (UMLS (HL7) C1552832) =Idea or Concept =TableFrame;
|
- 2009. HPA-23
- (UMLS (NCI) C0122297) =Pharmacologic Substance; Inorganic Chemical
| - 2059. hSMAD6
- [Encoded by MADH6 Gene (SMAD Family), ubiquitous (predominantly vascular endothelium) SMAD6 Protein Isoforms A (496-aa 53.5-kD) and B (235-aa) act similar to other MAD-proteins as second messengers distal to TGFBRs and contain an N-terminal DWA/MH1 domain and a C-terminal DWB/MH2 domain. An inhibitory SMAD phosphorylated by type 1 receptor kinase, SMAD6 acts as an antagonist of TGF-beta type 1 receptor signaling. A selective inhibitor of BMPs signaling; SMAD6 competes with SMAD4 for receptor-activated SMAD1. SMAD6 interacts with TGF-beta type I receptor superfamily members, SMAD1, HOXC8, and HOXC9. MADH6 and MADH7 form complexes. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0540682) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 2010. HPRT1
- [This gene is involved in purine/pyrimidine metabolism. ( NCI )] (UMLS (NCI) C1415701) HPRT1 Gene;
Hypoxanthine Phosphoribosyltransferase 1 (Lesch-Nyhan Syndrome) Gene =Gene or Genome | - 2060. hSMAD7
- [Encoded by MADH7 Gene (SMAD Family) and induced by TGF-beta and IFNG, ubiquitous (lung, vascular endothelium highest) 426-amino acid SMAD7 Protein is an inhibitory Activin/TGFBR1 signaling component containing DWA/MH1 and DWB/MH2 domains. SMAD7 lacks C-terminal phosphorylation sites of other MAD proteins, suggesting distinct regulation. Adaptor SMAD7 constitutively recruits nuclear E3 ubiquitin ligase SMURF2 to TGFBR complexes preventing SMAD2 access and causing proteasomal and lysosomal receptor degradation. SMAD7-expressing cells are susceptible to apoptosis induced by TGFB, TNFA, serum withdrawal, or loss of cell adhesion. SMAD7 decreases NFKB activity, promoting apoptosis. RAS suppresses SMAD7 inhibition of NFKB and potentiation of apoptosis. MADH7 and MADH6 form complexes. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0664910) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 2011. HPRT2
- [This gene plays a putative role in transcription. ( NCI )] (UMLS (NCI) C1415702) HPRT2 Gene;
Hypoxanthine Phosphoribosyltransferase 2 Gene =Gene or Genome | - 2061. hSNF2L
- [This protein is a member of the SWI/SNF family of proteins. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. ( NCI )] (UMLS (NCI) C0165820) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 2012. HPT B ACTE COMA W DLTA
- [ ] (UMLS (ICD9CM) C0375001) =Disease or Syndrome
| - 2062. HSNIK
- [Encoded by MAP3K14 Gene (MAP3K Family) and expressed in small intestine, spleen, thymus, peripheral leukocytes, testis, prostate, ovary, and colon, autophosphorylated 947-amino acid 104-kD cytoplasmic Ser/Thr Protein Kinase NIK is involved in NFKB activation. NIK selectively activates NFKB cascades of TNF/NGF receptors and IL1R type-I. TNFA acts through TRAF2; IL1 acts through IRAK1 and TRAF6. LTBR and CD95 also act through NIK. NIK appears to bind TRAFs 2, 5, and 6, IKKA, and NFKB2/p100. Binding to TRAF2 involves the TRAF2 N- and C-terminal regions. NIK induces NFKB2/p100 processing, degradation of phosphoserine-induced ubiquitinated destruction of IKBA, and release of cytoplasmic NFKB for nuclear translocation and kappa-B DNA-mediated gene expression. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1335946) MAP3K14;
MAP3K14 Protein;
Mitogen-Activated Protein Kinase Kinase Kinase 14;
NFKB-Inducing Kinase;
NIK;
Serine/Threonine Protein Kinase NIK =Amino Acid, Peptide, or Protein; Enzyme |
- 2013. HPT B ACTE COMA WO DLTA
- [ ] (UMLS (ICD9CM) C0375000) =Disease or Syndrome
| - 2063. HSORC1
- [Expressed by G1 cyclin-dependent kinase activated human ORC1L Gene (ORC1 Family), 861-aa 97-kDa nuclear Origin Recognition Complex Subunit 1 is the largest of 6 conserved subunits of the ORC complex that binds to the consensus ACS of Origins in an ATP-dependent manner, serves as a platform for assembly of additional initiation factors such as CDC6 and MCM proteins, initiates DNA replication, and is essential for viability. Bound to origins throughout the cell cycle, ORC and associated factors modulate local chromatin structure to facilitate replication initiation. Selectively phosphorylated during mitosis and unlike other ORC subunits, ORC1L levels vary during the cell cycle, regulated by ubiquitin-mediated proteolysis after replication initiation. Also involved in transcriptional silencing, ORC1L may interact with MYST histone acetyltransferase 2. (NCI) ( NCI )] (UMLS (NCI) C1335134) ORC1;
ORC1L;
Origin Recognition Complex 1;
Origin Recognition Complex Subunit 1;
Origin Recognition Complex Subunit 1 Homolog-Like;
Origin Recognition Complex Subunit 1-Like;
PARC1;
Replication Control Protein 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 2014. HPT B ACTE WO CM W DLTA
- [ ] (UMLS (ICD9CM) C0375005) =Disease or Syndrome
| - 2064. hSWI/SNF
- [hSWI/SNF is an ATP-dependent chromatin-remodeling complex implicated in the regulation of gene expression, cell cycle control, and oncogenesis. The complex facilitates transcriptional activation of specific genes by antagonizing chromatin-mediated transcriptional repression. Subunits of the complex include: BAF57, BAF60a,-b,-c, BAF155, BAF170, BRG-1, BRM, and hSNF5/INI1. BAF57 contains an HMG domain adjacent to a kinesin-like region and binds DNA. BAF155 and BAF170 are BRG-1-associated proteins with dimerization motifs for transcription factors. BRM and BRG-1 are ATPase subunits of the complex and co-activators for nuclear hormone receptors. BRG-1 interacts with BRCA1, a nuclear phosphoprotein transcription and recombination accessory factor. ( NCI )] (UMLS (NCI) C1337050) Human SWI/SNF =Amino Acid, Peptide, or Protein; Enzyme
|
- 2015. HPT B ACTE WO CM WO DLTA
- [ ] (UMLS (ICD9CM) C0375004) =Disease or Syndrome
| - 2065. HT-29
- [Human colonic ADENOCARCINOMA cells that are able to express differentiation features characteristic of mature intestinal cells such as the GOBLET CELLS. ( MSH )] (UMLS (NCI) C0282639) =Cell ;
|
- 2016. HPT B CHRN COMA W DLTA
- [ ] (UMLS (ICD9CM) C0375003) =Disease or Syndrome
| - 2066. HTC cell
- [immortalized cell line derived from liver carcinoma cells. ( CSP )] (UMLS (CSP) C0598613) =Cell =cell line;
neoplastic cell |
- 2017. HPT B CHRN COMA WO DLTA
- [ ] (UMLS (ICD9CM) C0375002) =Disease or Syndrome
| - 2067. hTERC
- [Telomerase RNA component is the ribonucleic acid subunit of telomerase. Telomerase uses the species-specific RNA sequences as the templates to synthesize GC-rich strand of telomeres, chromosome ends. ( NCI )] (UMLS (NCI) C0935992) hTR;
Telomerase RNA Component;
TERC =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
|
- 2018. HPT B CHRN WO CM W DLTA
- [ ] (UMLS (ICD9CM) C0375007) =Disease or Syndrome
| - 2068. hTLR7
- [Expressed in lung, placenta, spleen, brain, stomach, small intestine, and pre-dendritic cells by human TLR7 Gene (TLR Family), 104-aa 121-kDa (precursor) type I membrane protein Toll-Like Receptor 7 contains a TIR domain and 27 LRR repeats. TLR7 has a fundamental role in pathogen recognition and activation of innate immunity to microbial agents. Sharing structural and functional similarities, highly conserved TLRs recognize pathogen-associated molecular patterns expressed on infectious agents and mediate cytokine production necessary for effective immunity. TLR7 likely acts via MyD88 (TIR interaction) and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. (NCI) ( NCI )] (UMLS (CSP) C0971207) TLR7;
Toll-Like Receptor 7 =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor |
- 2019. HPT B CHRN WO CM WO DLTA
- [ ] (UMLS (ICD9CM) C0375006) =Disease or Syndrome
| - 2069. hTLR8
- [Expressed in lung, brain, heart, liver, placenta, monocytes, peripheral leukocytes, and CD11c+ immature dendritic cells by human TLR8 Gene (TLR Family), 1041-aa 120-kDa (precursor) type I membrane protein Toll-Like Receptor 8 contains a TIR domain and 24 LRR repeats. TLR8 has a fundamental role in pathogen recognition and activation of innate immunity to microbial agents. Sharing structural and functional similarities, highly conserved TLRs recognize pathogen-associated molecular patterns expressed on infectious agents and mediate cytokine production necessary for effective immunity. TLR8 likely acts via MyD88 (TIR interaction) and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. (NCI) ( NCI )] (UMLS (CSP) C0962444) TLR8;
Toll-Like Receptor 8 =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor |
- 2020. HPT C W HEPATIC COMA NOS
- [ ] (UMLS (ICD9CM) C1456265) Unspecified viral hepatitis C with hepatic coma;
=Disease or Syndrome | - 2070. hTLR9
- [ ] (UMLS (CSP) C0962445) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 2021. HPT C W/O HEPAT COMA NOS
- [ ] (UMLS (ICD9CM) C1456263) Unspecified viral hepatitis C without hepatic coma;
=Disease or Syndrome | - 2071. HTLV group
- [ ] (UMLS (CSP) C0920557) =Virus
|
- 2022. HPTPE
- [Encoded by human PTPRE Gene (PTP Family), alternative isoform 642-aa Protein Tyrosine Phosphatase Epsilon Isoform 2 is a cytoplasmic nonreceptor-type PTP with a distinct hydrophilic N-terminus and PTP catalytic domains. Alternative isoform 700-aa 81-kDa (precursor) Protein Tyrosine Phosphatase Receptor Type Epsilon Isoform 1 is a type I membrane protein receptor-type PTP with a short extracellular domain, a single transmembrane region, and two tandem intracytoplasmic catalytic domains. Studies of the mouse homolog suggest a regulatory role for PTPRE in RAS related signal transduction pathways, cytokine-induced SATA signaling, and activation of voltage-gated K+ channels. (NCI) More…
| - 2072. HTLV I
- [A retrovirus that infects T-cells (a type of white blood cell) and can cause leukemia and lymphoma. HTLV-1 is spread by sharing syringes or needles used to inject drugs, through sexual contact, and from mother to child at birth or through breast-feeding. ( NCI )] (UMLS (CSP) C0020094) =Virus ;
=BLV-HTLV Retrovirus;
|
- 2023. HPTPG
- [Expressed in many tissues (likely developmentally regulated in brain) by human PTPRG Gene (PTP Family), Protein Tyrosine Phosphatase Receptor Type G is a likely type I membrane protein receptor-type PTP with an extracellular region containing an eukaryotic-type CAH domain and a fibronectin type III domain, a single transmembrane region, and two tandem intracytoplasmic catalytic PTP domains. PTPs typically regulate cell growth, differentiation, and mitotic cycle. (NCI) ( NCI )] (UMLS (NCI) C1335555) Protein Tyrosine Phosphatase Gamma;
Protein Tyrosine Phosphatase Receptor Type Gamma Polypeptide;
Protein Tyrosine Phosphatase Receptor Type-G;
PTPG;
PTPRG;
Receptor Tyrosine Phosphatase Gamma;
Receptor-Type Protein Phosphatase Gamma;
RPTPG;
R-PTP-Gamma =Amino Acid, Peptide, or Protein; Receptor | - 2073. HTLV II
- [strain of primate T lymphotropic virus 2 that can transform normal T lymphocytes and can replicate in both T and B cell lines; associated with T cell hairy cell leukemia. ( CSP )] (UMLS (CSP) C0020099) =Virus ;
=BLV-HTLV Retrovirus;
|
- 2024. HPV
- [A recombinant vaccine of different types of HPV proteins which are well-conserved within types with a significant inter-type variation. ( NCI )] (UMLS (HL7) C1512511) HPV Vaccine;
Human Papilloma Virus Vaccine =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 2074. HTLV-1 INFECTION OTH DIS
- [ ] (UMLS (ICD9CM) C0375019) =Disease or Syndrome
|
- 2025. HPV
- [(pap-ih-LO-ma-VYE-rus) A virus that causes abnormal tissue growth (warts) and is often associated with some types of cancer. ( NCI )] (UMLS (NCI) C0021344) =Virus =Papilloma Virus;
| - 2075. HTLV-1 Related Malignancy
- (UMLS (NCI) C1333932) HTLV-1-Related Malignant Neoplasm;
=Neoplastic Process ;
|
- 2026. HPV 16 E6 Peptide
- [A synthetic peptide sequence of human papillomavirus (HPV) type 16 oncoprotein E6. The E6 oncoprotein is implicated in the tumorigenesis of cervical carcinoma. Vaccination with HPV 16 E6 peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against cells expressing the E6 oncoprotein, resulting in tumor cell lysis. ( NCI )] (UMLS (NCI) C0133938) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 2076. HTLV-I REX Gene
- [Rex gene of the HTLV-I virus. ( NCI )] (UMLS (NCI) C0079556) =Gene or Genome ;
|
- 2027. HPV DNA Probes
- [DNA probes specific for the identification of human papilloma virus. ( MSH )] (UMLS (NCI) C0012895) =Nucleic Acid, Nucleoside, or Nucleotide; Indicator, Reagent, or Diagnostic Aid
| - 2077. HTLV-I TAX Gene
- [Tax gene of the HTLV-I virus. ( NCI )] (UMLS (NCI) C0079559) =Gene or Genome ;
|
- 2028. HPV-16
- [A strain of the human papillomavirus virus, (HPV16), has been directly linked to cervical cancer and is significantly associated with invasiveness. The papillomavirus virus constitutes a protein coat (capsid) surrounding a circular, double-stranded DNA organised into coding and non-coding regions, and induces skin and mucosal epithelial lesions. Progression from low- to high-grade neoplasia is often associated with the integration of the HPV16 virus genome into the host chromosome. The event occurs with disruption or deletion of the E2 ORF followed by inactivation of the E2 regulatory protein. ( NCI )] (UMLS (NCI) C0999806) Human Papillomavirus-16;
=Virus | - 2078. HTLV-II INFECTN OTH DIS
- [ ] (UMLS (ICD9CM) C0375020) =Disease or Syndrome
|
- 2029. HPV-18
- [A strain of the human papillomavirus virus, (HPV18), has been directly linked to cervical cancer and plays a role in the pathogenesis of the disease. The papillomavirus virus constitutes a protein coat (capsid) surrounding a circular, double-stranded DNA organised into coding and non-coding regions, and induces skin and mucosal epithelial lesions. The virus integrates its DNA at specific chromosomal locations, such as 8q24 and 12q15, which harbours both HPV18 and HPV16. The use of molecular markers such as HPV18 DNA type may allow the identification of patients with early stage cervical cancer at high risk for disease recurrence. ( NCI )] (UMLS (NCI) C0999807) Human Papillomavirus-18;
=Virus | - 2079. HTLV-II REX Gene
- [Rex gene of the HTLV-II virus. ( NCI )] (UMLS (NCI) C0079563) =Gene or Genome ;
|
- 2030. HPV-6
- [Genital warts caused by HPV 6 and 11 are the most common STD in the United States. Over a million cases are seen per year. ( NCI )] (UMLS (NCI) C1005556) Human Papillomavirus Type 6;
Human Papillomavirus-6 =Virus | - 2080. HTLV-II TAX Gene
- [Tax gene of the HTLV-II virus. ( NCI )] (UMLS (NCI) C0079566) =Gene or Genome ;
|
- 2031. HPV-Related Adenocarcinoma
- (UMLS (NCI) C1334048) Human Papilloma Virus Related Adenocarcinoma;
Human Papilloma Virus-Related Adenocarcinoma;
=Neoplastic Process | - 2081. HTML Text
- [For marked-up text according to the Hypertext Mark-up Language. HTML markup is sufficient for typographically marking-up most written-text documents. HTML is platform independent and widely deployed. ( HL7V3.0 )] (UMLS (HL7) C1554986) =Idea or Concept =TextMediaType;
|
- 2032. HPV-Related Anal Squamous Cell Carcinoma
- [An anal squamous cell carcinoma related to infection with sexually transmittable human papilloma virus. ( NCI )] (UMLS (NCI) C1334049) Human Papilloma Virus Related Anal Squamous Cell Carcinoma;
Human Papilloma Virus-Related Anal Squamous Cell Carcinoma;
=Neoplastic Process | - 2082. HtmlLinkType
- [HtmlLinkType values are drawn from HTML 4.0 and describe the relationship between the current document and the anchor that is the target of the link ( HL7V3.0 )] (UMLS (HL7) C1553828) =Intellectual Product =CodeSystem;
=alternate;
stylesheet;
start;
next;
prev;
contents;
index;
glossary;
copyright;
chapter;
section;
subsection;
appendix;
help;
bookmark;
|
- 2033. HPV-Related Carcinoma
- (UMLS (NCI) C1334050) Human Papilloma Virus Related Carcinoma;
Human Papilloma Virus-Related Carcinoma;
=Neoplastic Process | - 2083. hToll
- [Expressed most in placenta, spleen, and myelomonocytic leukocytes by human TLR4 Gene (TLR Family), isoforms A-D of 96-kDa (precursor) type I membrane protein Toll-Like Receptor 4 contains a TIR domain and 21 LRR repeats. Sharing structural and functional similarities, highly conserved TLRs recognize pathogen-associated molecular patterns expressed on infectious agents and mediate cytokine production necessary for effective immunity. As part of the LPS receptor (with CD14 and LY96), TLR4 mediates the immune response to LPS in gram-negative bacteria. Binding to LY96 via the extracellular domain and to MyD88 and TIRAP via their TIR domains, TLR4 acts via MyD88, TIRAP, and TRAF6, leading to NF-kappa-B activation, cytokine secretion, and the inflammatory response. TLR4 Asn-526 and Asn-575 glycosylation seems necessary for the LPS-response. (NCI) ( NCI )] (UMLS (NCI) C1321919) TLR4;
tlr4 gene product;
TOLL;
Toll Homologue;
Toll-Like Receptor 4;
=Amino Acid, Peptide, or Protein; Receptor |
- 2034. HPV-Related Cervical Carcinoma
- (UMLS (NCI) C1334051) Human Papilloma Virus Related Cervical Carcinoma;
Human Papilloma Virus-Related Cervical Carcinoma;
=Neoplastic Process | - 2084. HTS1
- [ST5 protein contains a C-terminal region that shares similarity with the Rab 3 family of small GTP binding proteins. This protein preferentially binds to the SH3 domain of c-Abl kinase, and acts as a regulator of MAPK1/ERK2 kinase, which may contribute to its ability to reduce the tumorigenic phenotype in cells. (from LocusLink) ( NCI )] (UMLS (NCI) C0753627) P126;
P70;
P82;
ST5;
ST5 Protein;
Suppression of Tumorigenicity 5 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 2035. HPV-Related Cervical Squamous Cell Carcinoma
- (UMLS (NCI) C1334052) Human Papilloma Virus Related Cervical Squamous Cell Carcinoma;
Human Papilloma Virus-Related Cervical Squamous Cell Carcinoma;
=Neoplastic Process | - 2085. HTTP
- [Hypertext Transfer Protocol [RFC 2068].http://www.ietf.org/rfc/rfc2068.txt ( HL7V3.0 )] (UMLS (HL7) C1555015) =Idea or Concept =URLScheme;
|
- 2036. HPV-Related Endocervical Adenocarcinoma
- (UMLS (NCI) C1334053) Human Papilloma Virus Related Endocervical Adenocarcinoma;
Human Papilloma Virus-Related Endocervical Adenocarcinoma;
=Neoplastic Process | - 2086. HU
- [A country in Central Europe, northwest of Romania. (NCI) ( NCI )] (UMLS (NCI) C0020174) =Geographic Area
|
- 2037. HPV-Related Esophageal Squamous Cell Carcinoma
- (UMLS (NCI) C1334054) Human Papilloma Virus Related Esophageal Squamous Cell Carcinoma;
Human Papilloma Virus-Related Esophageal Squamous Cell Carcinoma;
=Neoplastic Process | - 2087. HU Protein
- [A DNA-binding and thermostable low-molecular-weight E. coli protein that resembles eukaryotic histones. Acts as a cofactor in transcriptional repression. (from IRB summaries) ( NCI )] (UMLS (NCI) C1333934) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 2038. HPV-Related Malignancy
- (UMLS (NCI) C1334055) Human Papilloma Virus-Related Malignancy;
Human Papilloma Virus-Related Malignant Neoplasm;
=Neoplastic Process | - 2088. HU/IFN-A
- (UMLS (NCI) C0338156) =Therapeutic or Preventive Procedure
|
- 2039. HPV-Related Penile Squamous Cell Carcinoma
- (UMLS (NCI) C1334056) Human Papilloma Virus Related Penile Squamous Cell Carcinoma;
Human Papilloma Virus-Related Penile Squamous Cell Carcinoma;
=Neoplastic Process | - 2089. HU/PTX
- (UMLS (NCI) C0281717) =Therapeutic or Preventive Procedure
|
- 2040. HPV-Related Squamous Cell Carcinoma
- (UMLS (NCI) C1334057) Human Papilloma Virus Related Squamous Cell Carcinoma;
Human Papilloma Virus-Related Squamous Cell Carcinoma;
=Neoplastic Process | - 2090. Hu3S193
- [A humanized monoclonal antibody directed against the Lewis Y antigen, a tumor-associated epithelial antigen, with potential antineoplastic activity. Following binding, monoclonal antibody Hu3S193 triggers an antibody-dependent cell-mediated cytotoxicity in cells expressing Lewis Y antigen. (NCI05) ( NCI )] (UMLS (NCI) C0879578) MoAb Hu3S193;
Monoclonal Antibody Hu3S193 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 2041. HPV-Related Verrucous Carcinoma
- (UMLS (NCI) C1334058) Human Papilloma Virus Related Verrucous Carcinoma;
Human Papilloma Virus-Related Verrucous Carcinoma;
=Neoplastic Process | - 2091. Hualapai Indian Tribe of the Hualapai Indian Reser
- (UMLS (HL7) C1554325) =Population Group =NativeEntityContiguous;
|
- 2042. HPV-Related Vulvar Squamous Cell Carcinoma
- (UMLS (NCI) C1334059) Human Papilloma Virus Related Vulvar Squamous Cell Carcinoma;
Human Papilloma Virus-Related Vulvar Squamous Cell Carcinoma;
=Neoplastic Process | - 2092. Huang Lian
- [A Chinese herb that has been used as a treatment for a variety of medical problems. It is being studied as an anticancer drug. ( NCI )] (UMLS (NCI) C0696725) =Pharmacologic Substance
|
- 2043. HPV16 E7
- (UMLS (NCI) C0069508) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 2093. HuB219
- [Encoded by human LEPR Gene (gp130 Cytokine Receptor Family), five Leptin Receptor isoforms are variously expressed in liver, hypothalamus, heart, small intestine, hematopoietic tissues, choroid plexus, prostate, ovary, lung, and kidney. Isoform E may be soluble. The 1165-amino acid 132.5-kD (precursor) type I membrane protein contains 3 fibronectin III-like domains and is TYR phosphorylated; the cytoplasmic domain appears essential for signal transduction. LEPR appears involved in regulation of fat metabolism through hypothalamic effects, angiogenesis, lymphopoiesis, and possibly reproduction. LEPR appears to activate JAK kinase and STAT3, -5, and -6. LEPR malfunction is associated with diabetes and obesity. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0385463) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 2044. HPV16 E7/PADRE 965.10
- [A synthetic agent derived from human papillomavirus (HPV) E7 nuclear protein which is used to produce vaccines against HPV infection and HPV-related neoplasms. HPV E7 oncogenic protein binds the retinoblastoma tumor suppressor protein, pRB, as well as a number of other cellular proteins, and serves as a transcriptional activator. This protein is important in the induction and maintenance of cellular transformation and is co-expressed in the majority of HPV-containing carcinomas. PADRE(R) is a proprietary family of molecules that enhances the immune systems response against an administered immunogen such as the HPV E7 nuclear protein. (NCI04) ( NCI )] (UMLS (NCI) C0338214) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 2094. HuG1-M195 monoclonal antibody
- [A humanized recombinant monoclonal antibody directed against CD33, a cell surface antigen found on myeloid leukemia blasts and early hematopoietic progenitor cells. Lintuzumab stimulates antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing CD33, resulting in a decrease in tumor burden. The humanized version of this monoclonal antibody exhibits less immunogenicity and improved binding affinity compared to its murine counterpart. ( NCI )] (UMLS (NCI) C0530093) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 2045. HR-max
- [The minimum time between successive cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. ( NCI )] (UMLS (NCI) C0744679) Maximum Heart Rate;
=Finding ;
| - 2095. Hughes Village
- (UMLS (HL7) C1550872) =Population Group =NativeEntityAlaska;
|
- 2046. HRAS
- [This gene plays a role in signal transduction and cellular communication. ( NCI )] (UMLS (NCI) C0079471) =Gene or Genome ;
| - 2096. HuHMFG1
- [A humanized monoclonal antibody directed against MUC1, a mucin glycoprotein overexpressed in breast and other carcinomas. Monoclonal antibody HuHMFG1 stimulates antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing MUC1, resulting in a decrease in tumor burden. (NCI04) ( NCI )] (UMLS (NCI) C1328017) Monoclonal Antibody HuHMFG1 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 2047. HRF
- (UMLS (NCI) C0687687) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 2097. human adenovirus 2
- [ ] (UMLS (CSP) C0205652) =Virus
|
- 2048. HRT REVAS BYPS ANAS NEC
- [ ] (UMLS (ICD9CM) C0176589) =Therapeutic or Preventive Procedure
| - 2098. Human Androgen Receptor Gene Assay
- [Human androgen receptor gene assay. This assay was used to detect X chromosomal inactivation for diagnosis of X-linked conditions, ie. Kennedy disease, agammaglobulinemia, and others. ( NCI )] (UMLS (NCI) C0796370) HUMARA;
HUMARA Analysis;
HUMARA Assay =Diagnostic Procedure |
- 2049. HRT/PERICAR DX PROC NEC
- [ ] (UMLS (ICD9CM) C0176595) =Diagnostic Procedure
| - 2099. Human Biology
- (UMLS (NCI) C0678657) =Occupation or Discipline
|
- 2050. Hs
- [Supernumerary maxillary left primary canine ( HL7V3.0 )] (UMLS (HL7) C1552153) =Body Part, Organ, or Organ Component =SUPERNUMERARY TEETH;
| - 2100. human birth weight
- [the first weight of an infant obtained within less than the first 60 completed minutes after birth; a full-size infant is one weighing 2500 g or more. ( CSP )] (UMLS (CSP) C0178684) =Organism Attribute ;
=body weight;
child physical development |
home
